Company Filing History:
4 out of 113 
2 out of 1,309 
1 out of 41 Years Active: 1989-2016
Title: The Innovative Contributions of John Francis DiJoseph
Introduction
John Francis DiJoseph is a notable inventor based in Woodbridge, NJ, with a remarkable portfolio of seven patents. His work primarily focuses on advancements in cytotoxic drug conjugates, which have significant implications in the field of medicine.
Latest Patents
DiJoseph's latest patents include innovative methods for preparing monomeric cytotoxic drug/carrier conjugates. These methods achieve a drug loading significantly higher than previously reported procedures, while also minimizing aggregation and maintaining a low conjugate fraction (LCF). His patents describe various compositions, including cytotoxic drug derivative/antibody conjugates and monomeric calicheamicin derivative/anti-CD22 antibody conjugates, along with their uses in therapeutic applications.
Career Highlights
Throughout his career, DiJoseph has made substantial contributions to the pharmaceutical industry. He has worked with prominent companies such as Wyeth Holdings Corporation and Wyeth, where he has applied his expertise in drug development and innovation.
Collaborations
DiJoseph has collaborated with notable professionals in his field, including Arthur Kunz and Justin Keith Moran. These collaborations have further enhanced his research and development efforts.
Conclusion
John Francis DiJoseph's innovative work in the field of cytotoxic drug conjugates showcases his significant contributions to medical science. His patents reflect a commitment to advancing therapeutic techniques and improving patient outcomes.